Michael Bader Selected Research

Bradykinin Receptors (Bradykinin Receptor)

9/2012	Blocking of bradykinin receptor B1 protects from focal closed head injury in mice by reducing axonal damage and astroglia activation.
8/2010	Inhibition of bradykinin receptor B1 protects mice from focal brain injury by reducing blood-brain barrier leakage and inflammation.
2/2009	The bradykinin B2 receptor in the early immune response against Listeria infection.
1/2009	Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema.
5/2008	Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors.
5/2008	Deficiency of bradykinin receptor B2 is not detrimental in experimental stroke.
11/2006	Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Bader Research Topics

Disease

42	Inflammation (Inflammations) 01/2022 - 12/2002
34	Hypertension (High Blood Pressure) 01/2022 - 06/2002
18	Cardiomegaly (Heart Hypertrophy) 01/2022 - 11/2002
15	Insulin Resistance 08/2020 - 02/2008
14	Fibrosis (Cirrhosis) 11/2020 - 08/2002
14	Obesity 05/2020 - 06/2008
13	Body Weight (Weight, Body) 12/2021 - 03/2005
11	Hypertrophy 12/2019 - 09/2002
10	Neoplasms (Cancer) 01/2022 - 01/2002
10	Ischemia 09/2008 - 01/2002
9	Myocardial Infarction 01/2017 - 04/2005
8	Pain (Aches) 01/2020 - 12/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2009
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2010
7	Infarction (Infarctions) 01/2011 - 02/2002
6	Weight Gain 01/2021 - 06/2008
6	Hyperalgesia 01/2016 - 12/2002
5	Atherosclerosis 01/2021 - 10/2009
5	Stroke (Strokes) 01/2020 - 02/2002
5	Heart Failure 01/2020 - 10/2004
5	Edema (Dropsy) 11/2015 - 01/2003
4	AIDS-Related Complex (ARC) 04/2022 - 03/2006
4	Melanoma (Melanoma, Malignant) 10/2021 - 04/2005
4	Proteinuria 01/2021 - 01/2004
4	Atrophy 12/2020 - 04/2016
4	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 01/2018
4	Neuralgia (Stump Neuralgia) 01/2020 - 03/2005
4	Infections 01/2020 - 01/2003
4	Pre-Eclampsia (Preeclampsia) 12/2019 - 09/2014
4	Pulmonary Arterial Hypertension 01/2019 - 01/2007
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 04/2006
4	Diabetes Mellitus 01/2019 - 12/2004
4	Necrosis 01/2017 - 01/2002
4	Wounds and Injuries (Trauma) 05/2016 - 02/2004
4	Fatty Liver 12/2013 - 06/2003
4	Heart Diseases (Heart Disease) 02/2013 - 01/2003
4	Vascular Remodeling 08/2011 - 09/2002
4	Hypoxia (Hypoxemia) 06/2008 - 02/2002
3	Thrombosis (Thrombus) 01/2022 - 12/2003
3	Pneumonia (Pneumonitis) 01/2021 - 12/2008
3	Hypertensive Nephropathy 11/2020 - 02/2014
3	Non-alcoholic Fatty Liver Disease 05/2020 - 08/2007
3	Mental Disorders (Mental Disorder) 01/2020 - 11/2003
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 02/2008
3	Carcinoid Tumor (Carcinoid) 01/2020 - 06/2002
3	Glucose Intolerance 01/2020 - 02/2008
3	Weight Loss (Weight Reduction) 03/2017 - 02/2009
3	Endotoxemia 01/2016 - 06/2007

Drug/Important Bio-Agent (IBA)

45	KininsIBA 01/2022 - 01/2002
23	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 06/2002
22	Angiotensin IIIBA 11/2020 - 02/2002
21	ReninIBA 01/2022 - 02/2002
20	BradykininIBA 01/2019 - 08/2002
17	AngiotensinsIBA 01/2022 - 01/2004
17	angiotensin I (1-7)IBA 01/2021 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2002
14	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2008
12	AngiotensinogenIBA 01/2020 - 02/2002
12	LeptinIBA 01/2020 - 02/2008
12	Peptides (Polypeptides)IBA 12/2018 - 11/2002
11	Messenger RNA (mRNA)IBA 01/2020 - 02/2002
8	LipidsIBA 10/2021 - 06/2003
8	Insulin (Novolin)FDA Link 01/2021 - 02/2008
8	LipopolysaccharidesIBA 12/2020 - 01/2003
8	2,5-dichloro-4-bromophenol (B 2)IBA 10/2011 - 12/2002
7	Streptozocin (Streptozotocin)FDA Link 01/2019 - 06/2002
7	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2017 - 06/2003
7	CytokinesIBA 12/2016 - 04/2004
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016 - 01/2003
7	EnzymesIBA 01/2016 - 02/2002
7	Bradykinin Receptors (Bradykinin Receptor)IBA 09/2012 - 11/2006
6	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2009
6	Tryptophan HydroxylaseIBA 02/2013 - 06/2002
5	Kallikreins (Kallikrein)IBA 01/2022 - 09/2002
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2020 - 02/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 08/2002
5	salicylhydroxamic acid (SHAM)IBA 01/2020 - 04/2005
5	CollagenIBA 12/2019 - 11/2006
5	AldosteroneIBA 09/2014 - 03/2005
4	Biological ProductsIBA 01/2022 - 04/2004
4	SaltsIBA 01/2020 - 02/2002
4	AcidsIBA 07/2018 - 06/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 03/2008
4	icatibantIBA 03/2013 - 05/2002
3	compound 21IBA 01/2022 - 03/2010
3	Blood Glucose (Blood Sugar)IBA 12/2021 - 03/2014
3	AlbuminsIBA 12/2021 - 11/2002
3	Prorenin ReceptorIBA 01/2021 - 12/2011
3	CholesterolIBA 01/2021 - 10/2009
3	Insulin ReceptorIBA 01/2021 - 01/2017
3	Angiotensin-Converting Enzyme 2IBA 12/2020 - 11/2008
3	CreatinineIBA 11/2020 - 01/2004
3	FR 173657IBA 01/2020 - 01/2009
3	Karyopherins (Importin)IBA 01/2020 - 01/2018
3	AVE 0991IBA 12/2019 - 11/2010
3	alamandineIBA 01/2019 - 04/2013
3	Pharmaceutical PreparationsIBA 07/2018 - 09/2014
3	ChemokinesIBA 12/2016 - 06/2009

Therapy/Procedure

9	Therapeutics 11/2020 - 01/2011
3	Intraperitoneal Injections 06/2018 - 02/2007